Rankings
▼
Calendar
EKSO FY 2021 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena
EKSO
Ekso Bionics Holdings, Inc.
$29M
FY 2021 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$11M
+26.6% YoY
Gross Profit
$7M
60.0% margin
Operating Income
-$14M
-123.0% margin
Net Income
-$10M
-86.8% margin
EPS (Diluted)
$-0.88
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$49M
Total Liabilities
$12M
Stockholders' Equity
$37M
Cash & Equivalents
$40M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$11M
$9M
+26.6%
Gross Profit
$7M
$5M
+33.1%
Operating Income
-$14M
-$13M
-7.5%
Net Income
-$10M
-$16M
+38.3%
← Q4 2020
All Quarters
Q1 2021 →